文献速递焦虑、强迫与应激相关障碍

创伤后应激障碍的神经生物学与治疗

Neurobiology and Treatment of Posttraumatic Stress Disorder.
PubMed 文献 · Am J Psychiatry · 2024-01-01

本文概述创伤后应激障碍(PTSD)的遗传、分子与神经环路特征,并更新循证心理治疗、药物治疗、神经调控与数字化治疗的进展。文章讨论PTSD的诊断、患病率、病程、风险因素、神经生物学机制、当前标准治疗及下一代治疗与预防策略的创新,最后提出将神经生物学进展与新型治疗及预防靶点整合的研究方向。

要点

  • PTSD的神经生物学与临床异质性给临床医生和研究者带来挑战,但对其机制及诊治预防策略正形成共识。
  • 本文更新了PTSD的遗传、分子与神经环路特征及循证心理治疗、药物治疗、神经调控与数字化治疗进展。
  • 文章涵盖诊断、患病率、病程、风险因素、神经生物学机制、当前标准治疗及下一代治疗与预防策略创新。

核心结论

  • 尽管PTSD的神经生物学复杂且具有生物学与临床异质性,但对其潜在机制及诊断、治疗和预防方法正形成共识。
  • 文章最后提出将本病神经生物学进展与新型治疗和预防靶点整合的研究方向。

研究设计与样本

  • 本文为概述性更新,总结并更新PTSD的遗传、分子和神经环路特征以及循证心理治疗、药物治疗、神经调控和数字化治疗的进展。

主要发现

  • 文章涉及PTSD的诊断、患病率、病程、风险因素、神经生物学机制、当前标准治疗以及下一代治疗和预防策略的创新。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The recent worldwide surge of warfare and hostilities exposes increasingly large numbers of individuals to traumatic events, placing them at risk of developing posttraumatic stress disorder (PTSD) and challenging both clinicians and service delivery systems. This overview summarizes and updates the core knowledge of the genetic, molecular, and neural circuit features of the neurobiology of PTSD and advances in evidence-based psychotherapy, pharmacotherapy, neuromodulation, and digital treatments. While the complexity of the neurobiology and the biological and clinical heterogeneity of PTSD have challenged clinicians and researchers, there is an emerging consensus concerning the underlying mechanisms and approaches to diagnosis, treatment, and prevention of PTSD. This update addresses PTSD diagnosis, prevalence, course, risk factors, neurobiological mechanisms, current standard of care, and innovations in next-generation treatment and prevention strategies. It provides a comprehensive summary and concludes with areas of research for integrating advances in the neurobiology of the disorder with novel treatment and prevention targets.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Shalev A, Cho D, Marmar CR, et al. Neurobiology and Treatment of Posttraumatic Stress Disorder. Am J Psychiatry. 2024. PMID: 39086292. doi:10.1176/appi.ajp.20240536

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。